The impact of sugar-sweetened beverage intake on rat cardiac function

Driescher, Natasha ; Joseph, Danzil E. ; Human, Veronique R. ; Ojuka, Edward ; Cour, Martin ; Hadebe, Nkanyiso ; Bester, Dirk ; Marnewick, Jeanine L. ; Lecour, Sandrine ; Lochner, Amanda ; Essop, M. Faadiel (2019-03-12)

CITATION: Driescher, N., et al. 2019. The impact of sugar-sweetened beverage intake on rat cardiac function. Heliyon, 5(3). doi:10.1016/j.heliyon.2019.e01357.

The original publication is available at https://www.sciencedirect.com/journal/heliyon

Article

Aims: Although there is evidence linking sugar-sweetened beverage (SSB) intake with the development of cardio-metabolic diseases, the underlying mechanisms remain unclear. The current study therefore evaluated the effects of SSB consumption by establishing a unique in-house in vivo experimental model. Main methods: Male Wistar rats were divided into two groups: a) one consuming a popular local SSB (SSB- Jive), and b) a control group (Control-water) for a period of three and six months (n = 6 per group), respectively. Rats were gavaged on a daily basis with an experimental dosage amounting to half a glass per day (in human terms) (SSB vs. water). Cardiac function was assessed at baseline (echocardiography) and following ex vivo ischemia-reperfusion of the isolated perfused working rat heart. Oral glucose tolerance tests and mitochondrial respiratory analyses were also performed. In addition, the role of non-oxidative glucose pathways (NOGPs), i.e. the polyol pathway, hexosamine biosynthetic pathway (HBP) and PKC were assessed. Key findings: These data show that SSB intake: a) resulted in increased weight gain, but did not elicit major effects in terms of insulin resistance and cardiac function after three and six months, respectively; b) triggered myocardial NOGP activation after three months with a reversion after six months; and c) resulted in some impairment in mitochondrial respiratory capacity in response to fatty acid substrate supply after six months. Significance: SSB intake did not result in cardiac dysfunction or insulin resistance. However, early changes at the molecular level may increase risk in the longer term.

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/123082
This item appears in the following collections: